Interpace Biosciences Inc. (IDXG): Zero long term debt, total assets $53M,...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 05/09/2018 11:00:58 AM

Wednesday, May 09, 2018 11:00:58 AM

Zero long term debt, total assets $53M, total liabilities $13M , current market cap a joke at $25M

Keep Last Read

Replies (2) Next 10 Prev Next

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/20/2024 09:19:21 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/20/2024 09:17:14 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:10:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:30:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:29:42 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:01:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:33:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:14:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:16:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:18 PM

InvestorsHub NewsWire

Only $200 per official company press release!